- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT04053179
Validation of a Connected Patch, an Alternative to Conventional Monitoring
Studienübersicht
Detaillierte Beschreibung
When patients operated on outside intensive care or intensive care units are hospitalized, vital signs are collected intermittently by various conventional devices. During the follow-up period of these patients, it is possible that abnormal vital signs that may identify clinical deterioration may appear a few minutes to a few hours before a serious adverse event (infection etc.) occurs. These signals often go unnoticed due to infrequent monitoring.
The establishment of teams to ensure a rapid response would improve the safety of hospitalized patients for whom the detection of abnormal vital signs predictive of clinical deterioration would generate an alarm. This system is based on the identification of patients at risk and the rapid intervention of the team.
One of the crucial issues is therefore the speed of the alarm and its reliability.
The evolution of electronic technology offers the possibility of using inexpensive portable devices (connected patches) that can provide information on vital signs in real time. Vital signs collected by these devices could be analyzed to predict clinical deterioration prior to hospital staff visits, especially at night and on weekends when staffing levels are generally lower.
The connected patch used in this research is the Scaléo Médical company's device "myAngel VitalSigns". The long-term objective would be to be able to use this connected patch in surgical departments to detect early a complication, particularly of a cardiovascular or respiratory nature, and therefore to treat it without wasting time. However, it has not been validated in a hospital setting; that is the purpose of the project.
The objective of this research is therefore to validate Scaléo Médical's connected patch in different locations: post-interventional surveillance room that approaches a conventional hospital room, operating room where artifacts are numerous.
Studientyp
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
-
Suresnes, Frankreich, 92150
- Hôpital Foch
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- patient over 18 and under 85 years of age
- patient requiring general anesthesia for extra-thoracic surgery
- the patient's position during the operation is in supine position only
- patient affiliated to or benefiting from social security, excluding State Medical Assistance
- patient with written consent
Exclusion Criteria:
- pregnant or breastfeeding patients
- patients known to have severe skin reactions to adhésives
- patient whose surgical procedure prevents the patch from being placed (intervention on the thorax)
- patients deprived of their liberty or under guardianship
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Sonstiges
- Zuteilung: N / A
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Experimental: Verbundene Patch-Validierung
|
Verwendung eines angeschlossenen Pflasters zur Erfassung von Blutdruck, Herzfrequenz, Atemfrequenz, arterieller Sauerstoffsättigung und Temperatur
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Concordance of blood pressure value measured by 2 different devices after surgery
Zeitfenster: 36 hours maximum after the surgery
|
Comparison between blood pressure measured by conventional medical monitoring device and by connected patch
|
36 hours maximum after the surgery
|
Concordance of heart rate value measured by 2 different devices after surgery
Zeitfenster: 36 hours maximum after the surgery
|
Comparison between heart rate measured by conventional medical monitoring device and by connected patch
|
36 hours maximum after the surgery
|
Concordance of respiratory rate value measured by 2 different devices after surgery
Zeitfenster: 36 hours maximum after the surgery
|
Comparison between respiratory rate measured by conventional medical monitoring device and by connected patch
|
36 hours maximum after the surgery
|
Concordance of arterial oxygen saturation value measured by 2 different devices after surgery
Zeitfenster: 36 hours maximum after the surgery
|
Comparison between arterial oxygen saturation measured by conventional medical monitoring device and by connected patch
|
36 hours maximum after the surgery
|
Concordance of temperature value measured by 2 different devices after surgery
Zeitfenster: 36 hours maximum after the surgery
|
Comparison between temperature measured by conventional medical monitoring device and by connected patch
|
36 hours maximum after the surgery
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Concordance of blood pressure value measured by 2 different devices during surgery
Zeitfenster: During surgery
|
Comparison between blood pressure measured by conventional medical monitoring device and by connected patch
|
During surgery
|
Concordance of heart rate value measured by 2 different devices during surgery
Zeitfenster: During surgery
|
Comparison between heart rate measured by conventional medical monitoring device and by connected patch
|
During surgery
|
Concordance of respiratory rate value measured by 2 different devices during surgery
Zeitfenster: During surgery
|
Comparison between respiratory rate measured by conventional medical monitoring device and by connected patch
|
During surgery
|
Concordance of arterial oxygen saturation value measured by 2 different devices during surgery
Zeitfenster: During surgery
|
Comparison between arterial oxygen saturation measured by conventional medical monitoring device and by connected patch
|
During surgery
|
Concordance of temperature value measured by 2 different devices during surgery
Zeitfenster: During surgery
|
Comparison between temperature value measured by conventional medical monitoring device and by connected patch
|
During surgery
|
Blood pressure artifact
Zeitfenster: From surgery to 36 hours maximum after the surgery
|
Value of blood pressure will be considered as artifact if systolic blood pressure value < 80 or > 200 and diastolic blood pressure > 110
|
From surgery to 36 hours maximum after the surgery
|
Heart rate artifact
Zeitfenster: From surgery to 36 hours maximum after the surgery
|
Value of heart rate will be considered as artifact if value < 40 or > 140
|
From surgery to 36 hours maximum after the surgery
|
Respiratory rate artifact
Zeitfenster: From surgery to 36 hours maximum after the surgery
|
Value of respiratory rate will be considered as artifact if value < 8 or > 36
|
From surgery to 36 hours maximum after the surgery
|
Arterial oxygen saturation artifact
Zeitfenster: From surgery to 36 hours maximum after the surgery
|
Value of arterial oxygen saturation will be considered as artifact if value < 85 %
|
From surgery to 36 hours maximum after the surgery
|
Acceptability of connected patch: numerical scale
Zeitfenster: During the surgery and through study completion
|
Evaluation of connected patch with a simple numerical scale between 0 and 10: 0 representing a very poor tolerance of the device and leading to premature interruption of the collection and 10 a perfect tolerance allowing the patch to be maintained for several consecutive days
|
During the surgery and through study completion
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Morgan Le Guen, Hôpital Foch
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Voraussichtlich)
Primärer Abschluss (Voraussichtlich)
Studienabschluss (Voraussichtlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Andere Studien-ID-Nummern
- 2017055F
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Produkt, das in den USA hergestellt und aus den USA exportiert wird
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Patch-Validierung
-
Coloplast A/SAbgeschlossen
-
Coloplast A/SAbgeschlossen
-
GE HealthcareNoch keine RekrutierungFetale Überwachung
-
Universitat Pompeu FabraHospital Clinic of Barcelona; Institute for Bioengineering of CataloniaNoch keine Rekrutierung
-
Baylor College of MedicineRekrutierungSchielen | AmblyopieVereinigte Staaten
-
Veradermics, Inc.RekrutierungWarzen | Gemeine Warze | Verruca vulgarisVereinigte Staaten
-
Angeline NguyenAbgeschlossen
-
Associazione Infermieristica per lo studio delle...Artsana S.p.a.AbgeschlossenWunden und Verletzungen | Abrieb | SchnittverletzungenItalien
-
LifeWatch Services, Inc.AbgeschlossenEntsättigung des BlutesVereinigte Staaten
-
Johns Hopkins UniversityZurückgezogenDruckgeschwür | Anzeichen und Symptome